Gsno Therapeutics, Inc.

Shelton, WA

UEI
RVXND4M68T65
CAGE
9NBD3
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • DOT Certified DBE
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
191 SE Vic King Rd, Shelton, WA 98584, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Modulation of protein s-nitrosylation signaling as a potential therapeutic breakthrough in rheumatoid arthritis R43AR083703 National Insititue of Arthritis and Musculoskeletal and Skin Diseases (NIH) $559,308

Quick answers

Is Gsno Therapeutics, Inc. registered in SAM.gov?

Yes. Gsno Therapeutics, Inc.'s SAM.gov registration is active through May 11, 2027.

What is Gsno Therapeutics, Inc.'s most recent federal award?

Gsno Therapeutics, Inc.'s most recent federal grant award is Modulation of protein s-nitrosylation signaling as a potential therapeutic breakthrough in rheumatoid arthritis (R43AR083703), from National Insititue of Arthritis and Musculoskeletal and Skin Diseases (NIH), on September 20, 2023.

On GovTribe

See Gsno Therapeutics, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login